Mayo Clinic: Institutional Perspectives in Neurology, Chaired by Brian G. Weinshenker, MD


Chaired by Brian G. Weinshenker, MD, the presentations also feature Mayo Clinic experts W. Oliver Tobin, MBBCh, BAO, PhD; Jessica Stulc, MD, MPH; and Orhun H. Kantarci, MD. [WATCH TIME: 1 hour, 30 minutes]

NeurologyLive® State of the Science events are short meetings designed to educate neurologists and APPs on the clinical benefits associated with the new science driving new thinking. Our renowned faculty focuses on the most relevant topics to ultimately improve patient care.


  • Atypical Forms and Presentations of Demyelinating Disease – W. Oliver Tobin, MBBCh, BAO, PhD
  • Newly Approved FDA S1P Oral Medications for Multiple Sclerosis – Jessica Stulc, MD, MPH
  • Recently FDA Approved Injectable (B-cell Depleting) Medications for MS – Orhun H. Kantarci, MD
  • Infections on MS Disease Modifying Treatments – Brian G. Weinshenker, MD
Related Videos
Peter J. McAllister, MD, FAAN
Video 6 - "Utilization of Neuroimaging in Alzheimer’s Disease"
Video 5 - "Contribution of Multiple Pathways to the Development of Alzheimer’s Disease"
Michael Levy, MD, PhD
Michael Levy, MD, PhD
Michael Kaplitt, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.